Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pathophysiologie Basierte Therapie Von früh Beginnenden Epileptischen Enzephalopathien

NCT02968966 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT02968966
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02968966 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pathophysiologie Basierte Therapie Von früh Beginnenden Epileptischen Enzephalopathien
Lead sponsor
University Hospital Tuebingen
Phase
Phase 2
Overall status
Withdrawn
Start date
December 1, 2018
Completion date
August 31, 2020
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

seizure, epileptic